Etiology of graft dysfunction in renal transplant recipients

Journal Title: International Archives of Integrated Medicine - Year 2019, Vol 6, Issue 3

Abstract

Background: Kidney transplantation is the preferred mode of renal replacement therapy for the end-stage renal disease, with dramatic improvements in patient and graft survival over the last 50 years. In the modern era of immunosuppression, 1-year patient survival is close to 98%, and 1-year allograft survival rates have improved to 90% for deceased donor kidney transplants and 95 % for living donor kidney transplants with some inter-center variability. The aim of the study: To elucidate the etiology of graft dysfunction among renal transplant recipients. Materials and methods: A retrospective study was conducted among 155 patients who underwent both cadavers and live donor transplant from October 2009 to March 2011 at a tertiary care center in Chennai, South India. All the transplant recipients were regularly followed with serum urea and creatinine, urine routine, calcineurin inhibitor drug levels in the serum, USG Abdomen, urine culture depending on the graft status. Graft dysfunction defined by a rise in the creatinine more than 25% or 0.3 to 0.5 mg per dl from the baseline. Those who developed graft dysfunction were presented for graft biopsy and managed based on the report accordingly. Results: Among the 155 transplant recipient patients, 66 (44%) patients developed graft dysfunction and underwent renal biopsy. The graft dysfunction was due to chronic allograft dysfunction (interstitial fibrosis and tubular atrophy) in 24 (15.4%) patients, acute cellular rejection in 13 (8.4%) patients, acute antibody-mediated rejection in 2 (1.3%) patients, acute tubular necrosis in 9 (5.8%) patients, calcineurin toxicity in 6 (3.9%) patients, thrombotic microangiopathy in 6 (3.9%) patients, IgA nephropathy in 3 (1.9%) patients and transplant renal artery stenosis in 1(0.6%) patient. Conclusion: Among the various causes, acute cellular, acute antibody rejection and chronic allograft nephropathy holds nearly 25% of the incidence of graft dysfunction. It indicates appropriate immunological evaluation, appropriate immunosuppression, use of induction agents in high-risk patients and protocol renal biopsy to identify early rejection in high-risk patient and appropriate early intervention is important to improve long-term term graft and patient survival.

Authors and Affiliations

S Thirumavalavan, Krishna Kumar, S. A. K. Noor Mohamed, R Vijaya Kumar

Keywords

Related Articles

Lipid profile in assessing the severity of cirrhosis

Background: Cirrhosis is a common hepatological disorder seen in clinical practice. Liver plays an essential role in lipid metabolism, several stages of lipid synthesis and transportation. It is reasonable to expect an a...

A study of risk factors for stroke and their effect on survival

Introduction: Stroke is global health problem and is a leading cause of disability. It is usually the end result of predisposing conditions that originated years before the ictus. Identification of its modifiable risk fa...

Role of central corneal thickness measurement in management of open angle glaucoma and glaucoma suspects in Calabar, Nigeria

Introduction: Central Corneal Thickness (CCT) is gaining increasing significance in the management of glaucoma patients due to the recognized relationship between CCT and intraocular pressure (IOP) levels. The Objective...

Echocardiography changes in pre and post-operative patients who under gone mitral valve replacement in concerned with left atrial size

Background: The most frequent cause of atrial fibrillation is atrial dilatation resulting from volume or pressure overload of the heart, which may occur in ischemic heart disease, valvular disease, dilated cardiomyopathy...

The role of corticosteroids in primary antiphospholipid antibody syndrome presenting as cerebral venous thrombosis in young females at peripartum

The clinical study of cerebral venous thrombosis in antiphospholipid antibody syndrome in young females at peripartum was done to study the incidence of antiphospholipid antibodies in highly susceptible population groups...

Download PDF file
  • EP ID EP675226
  • DOI -
  • Views 127
  • Downloads 0

How To Cite

S Thirumavalavan, Krishna Kumar, S. A. K. Noor Mohamed, R Vijaya Kumar (2019). Etiology of graft dysfunction in renal transplant recipients. International Archives of Integrated Medicine, 6(3), 313-318. https://europub.co.uk/articles/-A-675226